Tamtam Try Tamtam free
argenx logo

argenx

Developing antibody-based medicines

Your company? Suggest a correction

About argenx

Global immunology company focused on developing novel antibody-based medicines for severe autoimmune diseases through collaborations with leading researchers

Key facts

Industry
Biotechnology Research
Company size
1,001–5,000 employees
Headquarters
boston, massachusetts, United States
Founded
2008
Revenue
$4.2BFY2025, publicly reported
Website
argenx.com
LinkedIn
linkedin.com/company/argenx

Who should you contact at argenx?

Connect to Tamtam to see the decision-makers at argenx, with verified emails and phone numbers, and find more companies like it.

See who to contact, free

argenx account plan

argenx is a Dutch-Belgian immunology biotech selling VYVGART, the first approved FcRn blocker: $4.2 billion FY2025 product net sales, 1,863 employees.

Read the argenx account plan →

argenx at a glance

argenx is a B2B company in the Biotechnology Research industry, headquartered in boston, massachusetts, United States.

argenx was founded in 2008.

argenx has 1,001–5,000 employees.

argenx's revenue is $4.2B (FY2025, publicly reported).

Frequently asked questions about argenx

What is argenx's revenue?

argenx's revenue is $4.2B (FY2025, publicly reported).

How many employees does argenx have?

argenx has 1,001–5,000 employees.

Where is argenx headquartered?

argenx is headquartered in boston, massachusetts, United States.

Selling to companies like argenx?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies